Last Price
0.045
Today's Change
-0.001 (2.22%)
Day's Change
0.04 - 0.045
Trading Volume
13,528,136
Overview
Market Cap
5 Million
Shares Outstanding
122 Million
Avg Volume
31,680,921
Avg Price (50 Days)
0.08
Avg Price (200 Days)
0.52
PE Ratio
-0.01
EPS
-3.13
Earnings Announcement
13-May-2024
Previous Close
0.05
Open
0.04
Day's Range
0.0402 - 0.0453
Year Range
0.021 - 1.82
Trading Volume
13,592,641
Price Change Highlight
1 Day Change
-1.98%
5 Day Change
22.93%
1 Month Change
14.69%
3 Month Change
-70.33%
6 Month Change
-90.12%
Ytd Change
-88.50%
1 Year Change
-97.07%
3 Year Change
-99.97%
5 Year Change
-99.99%
10 Year Change
-100.00%
Max Change
-100.00%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
US Opens Probe Into 130,000 Ford Vehicles Over Hands-free Tech
2
CEO Morning Brief
Musk’s Trip to Beijing After India Snub Shows Power of China
3
CEO Morning Brief
BHP Mega Bid and US$10,000 Copper Expose Mining’s Biggest Problem
4
CEO Morning Brief
5
CEO Morning Brief
How US Allies Are Preparing for a Possible Second Trump Term
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
